On August 4, Canada’s Health Minister Patty Hajdu granted, by way of a Section 56 of the Controlled Drugs and Substances Act, permission for four terminally-ill Canadians to consume psychedelic drugs. The decision comes after months of careful maneuvering by TheraPsil, a Canadian non-profit seeking to treat end-of-life distress with psilocybin, the active ingredient in magic mushrooms.
Share this post